The Psoriasis Treatment Market TNF Inhibitors, Phosphodiesterase Inhibitors, Interleukin Blockers Type and Forecasts Till 2022
The Global Psoriasis Treatment Market was valued to be US$7.0 billion in 2016 and is expected to reach US$10.68 billion by 2022. Thus the market is expected to grow at a CAGR of 7.3% from 2016 to 2022. Psoriasis is a chronic non-communicable disorder in which the immune system sends wrong signals directing skin cells to grow too quickly which results in patches of skin to be deposited on the body surface. Psoriasis mostly affects the knees, elbows and scalp,...
View full press release